Delayed Nasdaq 01:50:40 2024-04-16 pm EDT 5-day change 1st Jan Change
1.75 USD -4.89% Intraday chart for HeartBeam, Inc. -18.41% -25.53%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
HeartBeam, Inc. Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias CI
Transcript : HeartBeam, Inc., Q4 2023 Earnings Call, Mar 20, 2024
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
HeartBeam, Inc. Announces First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo System for Synthesizing A 12-Lead ECG CI
HeartBeam, Inc. Receives Two New US Patents for Its Core Cardiac Monitoring Technology CI
HeartBeam, Inc. Announces Retirement of Richard Brounstein as Chief Financial Officer CI
HeartBeam, Inc. Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights CI
Transcript : HeartBeam, Inc., Q3 2023 Earnings Call, Nov 14, 2023
HeartBeam, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Certain Warrants of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2023. CI
Certain Stock Options of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2023. CI
Certain Common Stock of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2023. CI
Heartbeam, Inc. Appoints Richa Gujarati as Senior Vice President, Product CI
Transcript : HeartBeam, Inc., Q2 2023 Earnings Call, Aug 10, 2023
HeartBeam, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
HeartBeam, Inc. Appoints Michael R. Jaff to the Board of Directors CI
Heartbeam Appoints Ken Nelson and Mark Strome to the Board of Directors CI
ADRs End Lower, Numinus Wellness, Heartbeam Trade Actively DJ
Sector Update: Health Care Stocks Slipping Late Tuesday MT
Sector Update: Health Care Stocks Lower in Afternoon Trading MT
HeartBeam Signs New Collaboration Deal With Samsung; Shares Jump MT
HeartBeam, Inc. Announces Automated Cardiac Detection Patent Granted for Heartbeam Aimigo™ System CI
HeartBeam Files US FDA Application for HeartBeam AIMIGo System MT
HeartBeam, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Chart HeartBeam, Inc.
More charts
HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.84 USD
Average target price
5 USD
Spread / Average Target
+171.74%
Consensus
  1. Stock Market
  2. Equities
  3. BEAT Stock
  4. News HeartBeam, Inc.
  5. Alliance Global Partners Initiates HeartBeam at Buy With $10 Price Target